On May 17, 2026, the Director-General of the World Health Organization declared the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern \u2014 the organization’s highest alert. Then he convened the Emergency Committee, the expert body that the International Health Regulations say is supposed to advise him before he makes that call.<\/p>\n\n\n\n
He did it backwards. First time in WHO history.<\/p>\n\n\n\n
Two days later the committee met, reviewed the evidence, and confirmed the declaration unanimously. Temporary recommendations followed on May 22. From the outside, the whole sequence looks like a procedural shortcut that didn’t matter \u2014 the experts agreed anyway, so what’s the fuss? But the retroactive confirmation is precisely the tell. The bottleneck was never expertise, or data, or a genuine disagreement about whether a novel Ebola virus spreading internationally with no approved vaccine or treatment constituted a global emergency. Of course it constituted one. The bottleneck was the architecture \u2014 a committee-convening, consensus-seeking, closed-door deliberation process that, by its own procedural logic, takes days an outbreak doesn’t have.<\/p>\n\n\n\n
The interesting question isn’t whether Tedros Adhanom Ghebreyesus was right to bypass his own committee. He was. The question is what kind of system forces its chief executive to work around the very procedure designed to produce the outcome he needed \u2014 and then retroactively validates the workaround without changing the procedure. That question doesn’t point back to one man’s impatience. It points to the International Health Regulations, a treaty drafted in a different era to solve a different problem than the one that keeps killing people.<\/p>\n\n\n\n
A PHEIC \u2014 Public Health Emergency of International Concern \u2014 sounds, to anyone hearing the term for the first time, like the international equivalent of pulling a fire alarm. The world’s highest health alert. Surely it compels a response. Surely funding flows, borders coordinate, governments act.<\/p>\n\n\n\n
They don’t. Not because the system malfunctions, but because the system was never built to make them.<\/p>\n\n\n\n
The International Health Regulations, adopted in 2005, are a binding treaty on 196 States Parties. Their obligations run in several directions, but not the direction that matters when people are dying. Article 6 requires states to notify the WHO within 24 hours of assessing events that may constitute a PHEIC. Articles 5 and 13, read alongside Annex 1, require states to develop and maintain core public health surveillance and response capacities \u2014 though compliance has been thin from the start, and deadline extensions have been granted so routinely that the requirement is aspirational in practice. Article 44 asks states to collaborate with each other “to the extent possible” in detection, response, technical cooperation, and mobilizing financial resources.<\/p>\n\n\n\n
To the extent possible. Four words that convert a treaty obligation into a polite suggestion.<\/p>\n\n\n\n
When the Director-General declares a PHEIC under Article 12, temporary recommendations are issued under Article 15. The treaty text defines these as “non-binding advice.” That is what the world’s highest health alert actually delivers. Non-binding advice to sovereign states.<\/p>\n\n\n\n
What the IHR does bind, and binds tightly, is the other direction of failure entirely. Article 43 requires any state imposing trade or travel restrictions beyond WHO recommendations to provide scientific justification and report those measures within 48 hours. The entire legal architecture was constructed to prevent overreaction \u2014 governments shutting borders, cutting trade routes, punishing affected countries economically out of panic or political theatre. The IHR constrains what states habitually do too much of (trade restrictions) and requires essentially nothing of what they consistently do too little of (actually responding to the emergency in the affected country).<\/p>\n\n\n\n
This asymmetry isn’t a drafting error. It’s the design. The IHR was negotiated in the early 2000s, in the aftermath of SARS, when the governing fear among member states was economic damage from excessive quarantine measures. China’s economy had been battered by travel advisories. Toronto’s tourism sector had cratered. The political energy behind the IHR revision was directed at preventing that kind of overreaction \u2014 not at compelling underfunded, under-resourced countries to mount emergency responses they couldn’t afford. The treaty the negotiators built reflected the problem they were solving. It just wasn’t the problem that keeps recurring.<\/p>\n\n\n\n
The 2024 amendments, adopted at the 77th World Health Assembly in June 2024, didn’t fix this. They introduced a “Coordinating Financial Mechanism” built entirely on voluntary contributions \u2014 no binding funding commitments from wealthy states. Eleven countries rejected even these modest changes outright: the United States, Germany, Canada, Brazil, Italy, Argentina, Austria, the Czech Republic, Israel, the Netherlands, and the Philippines. For the remaining states, the amendments entered into force in September 2025. But the fundamental architecture remained intact: a system that can declare emergencies it has no power to resolve.<\/p>\n\n\n\n
How deep does the disconnect run between the international and the domestic? A 2024 Lancet study by Clare Wenham and Liam Stout mapped the emergency legislation of 48 WHO member states \u2014 less than a quarter of the total, and not a representative sample \u2014 and found that only 16% had any reference to “PHEIC” in their domestic law. Just 37.5% referenced the term “pandemic.” The WHO’s highest alert designation doesn’t exist in the legal frameworks of most of the countries nominally bound by it. The system can sound an alarm that most of its audience has no domestic legal obligation to hear.<\/p>\n\n\n\n
The system can declare. It cannot compel.<\/p>\n\n\n\n
Every PHEIC since 2005<\/strong>\n\nNine PHEICs have been declared under the IHR, and the compliance record with temporary recommendations is remarkably consistent \u2014 consistently poor. H1N1 (2009): up to 20 countries banned pork imports, directly contradicting WHO guidance that the virus was not transmitted through food. Polio (2014, ongoing): surveillance recommendations partially followed, travel vaccination requirements widely ignored. Ebola West Africa (2014): roughly a quarter of states imposed travel restrictions against WHO advice. Zika (2016): compliance was high, mostly because WHO recommended almost nothing that demanded action. Ebola Kivu (2019): trade and travel measures imposed beyond recommendations. COVID-19 (2020): WHO explicitly recommended against travel restrictions on January 30; by end of March, effectively all 196 States Parties had imposed border controls, and at least two-thirds failed to report them as required under Article 43. Mpox (2022): Emergency Committee split 9-6 against declaring; Tedros declared anyway, calling himself the \"tiebreaker.\" Mpox clade I (2024): second declaration for the same disease in two years, vaccine access for African nations months behind wealthy countries. Bundibugyo Ebola (2026): declared before the committee even convened. Nine alarms. The pattern doesn't need narration.<\/code><\/pre>\n\n\n\nBundibugyo<\/h3>\n\n\n\n
So what does the PHEIC system’s architecture mean in practice? That depends on the specific emergency. The 2026 Bundibugyo outbreak happens to expose every limitation simultaneously \u2014 no medical countermeasure, active armed conflict, confirmed international spread, and a funding vacuum that no IHR mechanism can fill.<\/p>\n\n\n\n
Bundibugyo ebolavirus is one of six known species in the genus. The two licensed Ebola vaccines \u2014 Merck’s Ervebo (FDA approved December 2019) and Johnson & Johnson’s Zabdeno\/Mvabea \u2014 were developed against the Zaire species and provide no cross-protection against Bundibugyo. Ebolaviruses do not cross-neutralize; immunity to one species confers nothing against another. The FDA-approved monoclonal antibody treatments, Ebanga and Inmazeb, both developed through the 2018\u20132020 PALM clinical trial in the DRC, are likewise Zaire-specific. Against Bundibugyo, the entire therapeutic arsenal developed over the past decade is useless.<\/p>\n\n\n\n
CEPI is fast-tracking three investigational vaccine candidates: rVSV-BDBV-GP from IAVI, ChAdOx1-BDBV from the University of Oxford and the Serum Institute of India, and an mRNA candidate from Moderna. A WHO expert consultation on May 28 assessed the Oxford candidate as potentially ready for clinical trial assessment within two to three months, contingent on additional animal data. The IAVI candidate requires an estimated seven to nine months before it’s ready for a clinical trial. Moderna’s timeline remains unspecified. Even the fastest of these paths leads to a clinical trial \u2014 not a deployable vaccine. After a trial comes regulatory review. After review comes manufacturing. After manufacturing comes distribution \u2014 into a conflict zone where supply chains are routinely looted or destroyed. The gap between where the science is today and a health worker in Ituri Province holding a syringe is measured in years, not months.<\/p>\n\n\n\n
The outbreak is expanding into terrain where classical public health containment is functionally impossible.<\/p>\n\n\n\n
As of June 1, WHO reported 344 confirmed cases and 60 confirmed deaths in the DRC, spread across 24 health zones in three provinces \u2014 Ituri, North Kivu, and South Kivu. The virus had reached Butembo and Goma by May 17\u201318. Fifteen confirmed cases had been identified in Uganda, including in Kampala \u2014 a city of several million with direct international air connections to Nairobi, Dubai, Addis Ababa, and beyond. Contact tracing was reaching roughly 45% of identified contacts. To get ahead of an Ebola outbreak, you need above 90%. The response was falling behind the virus by a factor of two.<\/p>\n\n\n\n
The available tools are early isolation, contact tracing, infection prevention, and safe burials \u2014 all of which require community trust and physical access to work. Eastern DRC has neither at scale.<\/p>\n\n\n\n
Ituri Province is contested by the ADF, an ISIS-linked armed group responsible for mass killings of civilians, CODECO ethnic militias, and the Rwanda-backed M23, which controls significant territory in North Kivu. Health facilities are either destroyed or operating under threat. Community engagement teams \u2014 the people who knock on doors, trace contacts, explain why safe burial matters \u2014 cannot operate safely in areas under active armed-group control. Nearly ten million people in the affected provinces face acute hunger, which means populations are mobile, malnourished, harder to find, and largely beyond the reach of health systems or messaging.<\/p>\n\n\n\n
The methods are nineteenth-century public health. The operating environment is a twenty-first-century war zone.<\/p>\n\n\n\n
“We cannot build community trust or isolate the sick while bombs are falling,” Tedros said in late May, after visiting the region.<\/p>\n\n\n\n
He was stating the obvious. But the obvious is the argument. The PHEIC generated temporary recommendations \u2014 non-binding advice addressed to 196 sovereign states. What the outbreak actually requires is a vaccine that doesn’t exist, a ceasefire that no health authority can impose, and a funded response plan that no mechanism in the International Health Regulations can compel anyone to pay for. The distance between what the declaration produces and what the emergency demands is not a gap that better management would close. It is a limitation built into the instrument.<\/p>\n\n\n\n
The Bundibugyo virus<\/strong>\n\nFirst identified in 2007 in Bundibugyo District, Uganda, Bundibugyo ebolavirus had caused only small, geographically isolated outbreaks before 2026 \u2014 which is precisely why no vaccine existed for it. Historical case fatality rates are lower than Zaire's (roughly 25% versus 50\u201390%), but the virus has been poorly studied because outbreaks never lasted long enough or spread far enough to attract sustained research investment. The species-specificity problem in ebolavirus vaccine development is fundamental: no cross-neutralization among the six known species. A vaccine effective against Zaire does nothing against Bundibugyo. The three CEPI-backed candidates \u2014 rVSV-BDBV-GP (IAVI, 7\u20139 months to clinical trial readiness), ChAdOx1-BDBV (Oxford\/Serum Institute of India, 2\u20133 months to trial assessment pending animal data), and an mRNA candidate (Moderna, timeline unspecified) \u2014 are the entire pipeline.<\/code><\/pre>\n\n\n\nThe last time<\/h3>\n\n\n\n
The question forming at this point is unavoidable: hasn’t the system been here before?<\/p>\n\n\n\n
It has. And it remembers. It just can’t act on what it remembers.<\/p>\n\n\n\n
The 2014 West Africa Ebola epidemic followed a structure that should by now be recognizable. First cases in Guinea, December 2013. WHO notified, March 2014. By June, M\u00e9decins Sans Fronti\u00e8res had publicly declared the outbreak “out of control” \u2014 a judgment the WHO did not share, at least not publicly. The WHO didn’t declare a PHEIC until August 8, 2014 \u2014 138 days after notification, with more than 1,700 reported cases and over 960 dead by that point.<\/p>\n\n\n\n
The delay was not incompetence. It was calculation \u2014 and it reveals how deeply the IHR’s design asymmetry had been internalized by the institution supposedly operating above it. WHO leadership feared that a PHEIC declaration would trigger precisely the overreaction the IHR was built to prevent: trade and travel restrictions that would devastate three of the world’s poorest countries. Saudi Arabia’s probable restriction on West African Muslims attending the Hajj was discussed internally, according to peer-reviewed analyses of the deliberations \u2014 the economic and political consequences for Guinea, Liberia, and Sierra Leone would have been severe. Airlines were already reducing flights. Foreign investors were pulling out. A formal PHEIC, WHO’s leadership calculated, would accelerate the economic collapse it was supposed to help prevent.<\/p>\n\n\n\n
Dr. Sylvie Briand, then heading WHO’s Pandemic and Epidemic Diseases Department, wrote internally in June 2014 that she did not think declaring a PHEIC would “help fight the epidemic at this stage,” because “one has to make recommendations and these risk hurting the country without helping public health.” She described invoking the IHR as “a last resort.”<\/p>\n\n\n\n
The catastrophic economic consequences arrived regardless. Aggregate losses for the three countries exceeded 12% of their combined GDP \u2014 driven substantially by the trade and travel restrictions other states imposed in spite of the IHR’s prohibition. At least 40 countries imposed travel restrictions against WHO advice. The system designed to prevent economic punishment could not prevent it. And by delaying the declaration to minimize that risk, WHO allowed the outbreak to reach a scale that multiplied every cost \u2014 human, economic, institutional.<\/p>\n\n\n\n
Final toll: 28,616 cases. 11,310 dead.<\/p>\n\n\n\n
Then the reform season opened.<\/p>\n\n\n\n
The Harvard-LSHTM Independent Panel, published in The Lancet in November 2015, proposed ten structural reforms. Among them: a transparent, politically protected standing Emergency Committee empowered to declare emergencies by majority vote, replacing the ad hoc system. An independent Accountability Commission for system-wide assessment. Binding data-sharing frameworks. The Ebola Interim Assessment Panel, reporting in July 2015, recommended what became the single most-cited fix across every post-2014 review: an intermediate alert level below PHEIC, enabling graduated early engagement before a crisis reached full emergency threshold. Nearly every expert body that examined the 2014 failure arrived at the same conclusion: the system needed a way to respond before the alarm reached maximum volume.<\/p>\n\n\n\n
Most of these proposals died between recommendation and implementation. Not because they were forgotten \u2014 the WHO references them in annual reports, cites them in reform documents, points to them as evidence of institutional learning. They died because implementing them required the consent of the same member states whose behavior they were designed to constrain.<\/p>\n\n\n\n
The WHO Health Emergencies Programme was created in July 2016 \u2014 a genuine structural addition, and the reform most often cited as proof the system responded to 2014. But its own independent oversight committee later concluded it “does not have the ability to respond to a pandemic.” It was built for outbreaks of the scale and severity of West Africa Ebola. The next crisis that tested the system was COVID-19. The Contingency Fund for Emergencies was established with a target of $100 million \u2014 a floor, not a ceiling, in the view of the experts who recommended it. In 2025, according to WHO’s own annual report, the fund received $10.6 million in contributions from 11 member states and the WHO Foundation \u2014 while releasing nearly $30 million that year for 24 emergencies across 40 countries. Spending three times what it took in, from a fund that was never within shouting distance of adequate.<\/p>\n\n\n\n
Then there was the Pandemic Emergency Financing Facility \u2014 the World Bank’s flagship attempt to securitize pandemic risk through insurance-linked bonds, launched in 2017 with considerable fanfare. The facility raised $425 million through pandemic bonds and insurance swaps, paying investors approximately $100 million in coupon payments over the life of the instruments. The facility’s trigger criteria were so restrictive that by the time COVID-19 qualified for a payout, the pandemic was already killing thousands daily across multiple continents. The payout, when it finally came, was dwarfed by what investors had already collected. Lawrence Summers, the former World Bank chief economist, called the whole venture “an embarrassing mistake” \u2014 a symptom of “financial goofiness.” The World Bank did not renew the bonds when they matured in July 2020.<\/p>\n\n\n\n
The reform scorecard, in other words, reads: one understaffed programme, one chronically underfunded emergency kitty, and one financial instrument that enriched investors while an actual pandemic raged. The things the system built after 2014 failed the very test they were built to pass.<\/p>\n\n\n\n
And the intermediate alert level \u2014 the single reform nearly every expert panel identified as most critical for preventing delayed responses in the future? Debated for the better part of a decade. Never adopted. The 2024 IHR amendments instead introduced a “pandemic emergency” tier above PHEIC \u2014 adding escalation capacity when the diagnosed problem was the system’s inability to engage earlier. The system got a higher gear. What it needed was a lower one. As of June 2026, there is still no graduated mechanism for early response \u2014 no way for the WHO to engage at anything less than maximum volume.<\/p>\n\n\n\n
The pattern isn’t a failure to learn. The system learned the right lessons after 2014. It identified the correct structural fixes. It proved constitutionally incapable of implementing them.<\/p>\n\n\n\n
The pattern beneath the pattern<\/h3>\n\n\n\n
It would be comforting to treat 2014 as uniquely bad \u2014 the wrong leader at the wrong moment, a system caught flat-footed for the first time. But the same dynamics have reproduced with different variables and an identical outcome, which means the explanation has to be structural, not biographical. And the deeper you look at the pattern, the worse it gets \u2014 because the mechanism doesn’t just fail to work. It works against itself.<\/p>\n\n\n\n
The 2018\u20132020 DRC Ebola outbreak in Kivu: declared in August 2018, it would eventually kill over 2,200 people \u2014 the second-deadliest Ebola outbreak in history at the time. The Emergency Committee convened and declined to recommend a PHEIC three consecutive times \u2014 October 2018, April 2019, June 2019. The reasoning each time emphasized that the outbreak, while severe, did not meet the IHR criteria for international spread. By the third refusal, the virus had already crossed into Uganda, killing a five-year-old boy and his grandmother in Kasese district. The committee still said no. The stated reason for not declaring: the risk of international spread was low, and a PHEIC could damage the DRC’s economy. The same logic, almost verbatim, that had delayed the 2014 declaration by 138 days.<\/p>\n\n\n\n
The PHEIC was declared on July 17, 2019, only after a case appeared in Goma \u2014 a city of two million with an international airport, sitting on the Rwandan border. Goma triggered what the epidemiological evidence could not: political salience. Nearly a full year into an outbreak that had already killed more than 1,600 people.<\/p>\n\n\n\n
Different Director-General. Different geography. Different pathogen context. Same architecture, same result.<\/p>\n\n\n\n
The compliance record across all PHEICs compounds the picture. During H1N1 in 2009, up to 20 countries imposed pork import bans contradicting WHO guidance that the virus was not transmitted through food. During 2014 Ebola, approximately a quarter of states imposed travel restrictions against WHO advice. During COVID-19, WHO explicitly recommended against travel restrictions on January 30, 2020. By end of March, effectively every state party had imposed them. At least two-thirds failed to report those measures to WHO as required under Article 43 \u2014 turning the IHR’s central enforcement mechanism into dead letter within eight weeks of the declaration.<\/p>\n\n\n\n
The mpox declarations confirmed the pattern in yet another register. July 2022: the Emergency Committee voted 9 to 6 against a PHEIC; Tedros declared one anyway, calling himself the “tiebreaker” \u2014 stretching the procedural norms further than they had ever been stretched. And the declaration itself? Within weeks, wealthy nations had secured the vast majority of available vaccine doses. The WHO’s recommendation of equitable access became, as usual, non-binding advice that nobody was bound by. August 2024: a second mpox PHEIC, for clade I spread across Africa \u2014 a more dangerous variant, concentrated in the DRC and neighbouring countries, with vaccine access for African nations months behind wealthy ones. The same continent, again, bearing the burden while the system processed its own procedures.<\/p>\n\n\n\n
But the sharpest finding cuts deeper than the pattern \u2014 it goes to the mechanism itself. Research published in the British Journal of Political Science analyzed the COVID-19 response and found that PHEIC declarations explicitly recommending against travel restrictions were associated with an increase in states imposing them. The logic is simple and devastating: when the WHO declares the highest possible alert and simultaneously advises governments not to close borders, governments hear the alert and ignore the advice. The declaration functions as a severity signal. Governments respond to the severity \u2014 not to the recommendation stapled to it. Nationalist governments, the study found, were especially likely to impose restrictions and to do so faster, drawn to policies that associate disease with foreigners.<\/p>\n\n\n\n
The PHEIC mechanism doesn’t merely fail to prevent the overreaction it was designed to constrain. It amplifies it. The alarm bell triggers the panic it was supposed to prevent, and the treaty has no mechanism to do anything about it except issue more non-binding advice.<\/p>\n\n\n\n
That isn’t a fixable malfunction. That is a mechanism working against itself by design.<\/p>\n\n\n\n
Inside the Emergency Committee<\/strong>\n\nEmergency Committees are not standing bodies. Each is convened ad hoc by the Director-General from the IHR Expert Roster, deliberates behind closed doors, and seeks consensus. A 2024 study in Global Studies Quarterly by Frossard Pagotto and Eccleston-Turner found that PHEIC determinations are \"fundamentally political despite WHO claims of technocratic neutrality,\" with each committee operating as \"sui generis\" \u2014 its own internal legal order, shaped by its particular composition, the pressures bearing on its members, and the negotiating dynamics of the room. The process presents as scientific assessment. From inside, it is negotiation.<\/code><\/pre>\n\n\n\nThe architecture of impotence<\/h3>\n\n\n\n
Every simpler explanation has now been stripped away. Speed wasn’t the problem \u2014 Tedros bypassed the committee in 2026 and the outbreak kept burning. Knowledge wasn’t the problem \u2014 the system correctly diagnosed its own failure modes after 2014 and designed the right reforms. Proposals weren’t the problem \u2014 the reforms were costed, debated, and mostly shelved. Leadership wasn’t the problem \u2014 the pattern persists across Directors-General, pathogens, decades. The only question left is structural.<\/p>\n\n\n\n
Why can’t this system do the thing it appears to exist to do?<\/p>\n\n\n\n
Because the WHO’s authority is, as political scientist Colin McInnes argued in International Affairs in 2015, permanently “on loan” from member states. The entities the IHR is trying to govern are the same entities that govern the IHR. The governed are simultaneously the governors. This circularity generates three interlocking dysfunctions that no individual reform can reach, because they are not bugs in the system \u2014 they are properties of the structure.<\/p>\n\n\n\n
The first is the consent-authority paradox. After SARS in 2003, Director-General Gro Harlem Brundtland acted with genuine assertiveness \u2014 publicly criticizing China for concealing the outbreak and issuing WHO’s first-ever emergency travel advisory without member-state consent. It worked. SARS was contained. But the reward for that success was political backlash: member states accused the WHO of exceeding its mandate, of acting without authorization. The institution absorbed the lesson that acting decisively meant jeopardizing the cooperation of the states whose consent underwrites the organization’s authority. After H1N1 in 2009, proposals for a more operational WHO crisis role were rejected by the same governments that would, five years later, blame the organization for passivity during Ebola.<\/p>\n\n\n\n
The cycle is mechanical: states refuse the authority that would enable effective response, then condemn the institution for lacking it. And the condemnation itself becomes the justification for further withholding authority \u2014 the institution failed last time, so why would we trust it with more power?<\/p>\n\n\n\n
The second dysfunction is the enforcement vacuum. States violate IHR obligations without consequence \u2014 and they know it. When two-thirds of states failed to report their border measures during COVID-19 as required under Article 43, nothing happened. No investigation. No sanction. No public accounting. Compliance monitoring consists of the State Party Self-Assessment Annual Report, known as SPAR \u2014 a self-graded questionnaire with no independent verification. Countries rate their own preparedness and compliance. The WHO has no inspectorate, no sanctioning power, no enforcement arm of any kind. The 2024 amendments addressed this gap by creating a States Parties Committee whose mandate is explicitly “facilitative and consultative in nature only” and “non-adversarial, non-punitive.” Read that language carefully. A compliance body whose founding charter precludes the adversarial and punitive functions that would make compliance enforceable. The system’s own attempt to correct its enforcement deficit produced an institution that is, by design, toothless.<\/p>\n\n\n\n
The third dysfunction is the most corrosive, because it is a perverse incentive wired into the system’s core logic. States that report outbreaks honestly and transparently get punished \u2014 not by the WHO, but by other states imposing the very trade and travel restrictions the IHR was supposed to prevent. Guinea, Liberia, and Sierra Leone lost over 12% of their combined GDP during the 2014 Ebola epidemic, with much of that damage coming from other countries’ overreaction rather than the virus itself. This creates a rational incentive to delay, minimize, or conceal \u2014 because transparency invites economic punishment the treaty cannot stop.<\/p>\n\n\n\n
And the WHO itself internalized this incentive in 2014, when it delayed the Ebola PHEIC partly to shield affected countries from the consequences of being declared a global emergency. The institution designed to protect against outbreaks adopted the same calculus as the states it was supposed to be governing.<\/p>\n\n\n\n
The IHR has procedural teeth in one direction only. It demands justification from states that overreact. It demands nothing from states that don’t act at all. No mechanism compels a wealthy country to fund a response in a poor one. No mechanism penalizes inaction. No mechanism converts a declaration into resources, personnel, or medical countermeasures.<\/p>\n\n\n\n
Correcting this asymmetry would require member states to grant the WHO genuine enforcement authority \u2014 the power to compel funding, mandate resource deployment, penalize noncompliance with response obligations the way Article 43 at least nominally constrains trade restrictions. That authority would need to come from the same states whose behavior it would constrain. And the consent-based governance model cannot generate the consent to override itself. The actors who would need to change the system are the actors who benefit \u2014 or believe they benefit \u2014 from its current design. Wealthy states that might be compelled to fund responses in poor countries have no interest in creating that compulsion. Poor countries that might gain from it lack the political leverage to demand it. The structure reproduces itself because the distribution of power within it prevents the redistribution of power that would change it.<\/p>\n\n\n\n
The problem is not operational. It is constitutional. And constitutional problems are, by definition, the ones the existing constitution cannot solve.<\/p>\n\n\n\n
The Bundibugyo outbreak is not waiting for the architecture to sort out its contradictions. As of early June, confirmed cases were climbing in a conflict zone with no approved vaccine, no specific treatment, and contact tracing reaching fewer than half of identified contacts. The fastest investigational vaccine candidate is months from a clinical trial \u2014 not from deployment, from a trial. The PHEIC’s temporary recommendations expire in three months unless renewed. And no mechanism in the International Health Regulations converts those recommendations into anything the situation demands: funded response, medical countermeasures, operational access in a war zone. The declaration produced exactly what it was engineered to produce. Not what the outbreak needs. What the treaty’s architects, two decades ago, decided was sufficient.<\/p>\n\n\n\n
On May 17, the Director-General bypassed his own committee to sound the alarm faster. Two days later the committee confirmed he’d been right. On May 22, the recommendations were published \u2014 non-binding advice, addressed to sovereign states whose consent is the only source of the authority being exercised upon them. The procedural shortcut, the retroactive validation, the governed governing the governors. The whole architecture compressed into five days.<\/p>\n\n\n\n
A system that can diagnose the emergency it cannot treat. Led by someone who can declare the crisis he is not empowered to resolve.<\/p>\n\n\n\n